$NBIO Nascent Successfully Completes 2nd Cohort Dosing in Key Phase 1 Metastatic Brain Cancer Trial https://www.accesswire.com/681450/Nascent-Successfully-Completes-2nd-Cohort-Dosing-in-Key-Phase-1-Metastatic-Brain-Cancer-Trial